# CEPI

leads the 100 Days Mission, a coordinated framework to compress the pathogen-to-authorized-vaccine timeline, publishing rapid-response manufacturing frameworks and emergency clinical- research principles with academic and industry partners.


Source: https://cn.bioecon.ru/companies/cepi/
Updated: 2026-08-15

- 国家: Norway

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 隶属机构 | 流行病防范创新联盟（CEPI） | https://pmc.ncbi.nlm.nih.gov/articles/PMC12389860/, https://static.cepi.net/downloads/2023-12/Programme-Document_April-2019.pdf, https://static.cepi.net/downloads/2025-04/CEPI%20Board%20of%20Directors%20report,%20Annual%20Accounts%20and%20Auditors%20report%202024_V1.pdf, https://static.cepi.net/downloads/2025-09/CEPI-Backgrounder_Aug-2025.pdf |
| 研究方向 | “100天使命”旨在加速疫苗研发、快速响应生产框架及针对流行性/大流行病原体的疫苗平台 | https://cepi.net/100-days-mission, https://pmc.ncbi.nlm.nih.gov/articles/PMC12389860/, https://static.cepi.net/downloads/2023-12/Programme-Document_April-2019.pdf, https://static.cepi.net/downloads/2025-09/CEPI-Backgrounder_Aug-2025.pdf, https://static.cepi.net/downloads/2026-02/CEPI%203.0%20Strategy%20Report%20DIG%20ENG%20FINAL.pdf |
| 实验设施 | 集中实验室网络、临床前模型网络及疫苗生产设施网络 | https://static.cepi.net/downloads/2025-04/CEPI%20Board%20of%20Directors%20report,%20Annual%20Accounts%20and%20Auditors%20report%202024_V1.pdf, https://static.cepi.net/downloads/2026-02/CEPI%203.0%20Strategy%20Report%20DIG%20ENG%20FINAL.pdf |
| 科研资助 | 投资全球研发与制造合作，包括候选疫苗、平台及使能科学项目 | https://cepi.net/100-days, https://static.cepi.net/downloads/2025-04/CEPI%20Board%20of%20Directors%20report,%20Annual%20Accounts%20and%20Auditors%20report%202024_V1.pdf, https://static.cepi.net/downloads/2026-02/CEPI%203.0%20Strategy%20Report%20DIG%20ENG%20FINAL.pdf |
| 论文产出 | 战略报告、年度账目、董事会报告及疫苗研发/生产技术框架 | https://pmc.ncbi.nlm.nih.gov/articles/PMC12389860/, https://static.cepi.net/downloads/2025-04/CEPI%20Board%20of%20Directors%20report,%20Annual%20Accounts%20and%20Auditors%20report%202024_V1.pdf, https://static.cepi.net/downloads/2026-02/CEPI%203.0%20Strategy%20Report%20DIG%20ENG%20FINAL.pdf |
| 主要研究人员 | Richard Hatchett（首席执行官）、Nicole Lurie（应急响应执行总监）及多位职能执行总监 | https://cepi.net/cepi-board, https://pmc.ncbi.nlm.nih.gov/articles/PMC12389860/, https://static.cepi.net/downloads/2023-12/Programme-Document_April-2019.pdf, https://static.cepi.net/downloads/2024-08/CEPI%20B26%2001.01%20March%202024%20minutes%20FINAL.pdf |
| 员工人数 | 330名员工（截至2024年12月31日） | https://static.cepi.net/downloads/2024-03/CEPI%20Board%20of%20Directors'%20report,%20Annual%20Accounts%20and%20Auditors%20report%202023.pdf, https://static.cepi.net/downloads/2025-04/CEPI%20Board%20of%20Directors%20report,%20Annual%20Accounts%20and%20Auditors%20report%202024_V1.pdf |

独立来源: pmc.ncbi.nlm.nih.gov

## 技术

- [生物应急准备](https://cn.bioecon.ru/technology/bio-emergency-preparedness/)